US Stocks
/
NewAmsterdam Pharma Company N.V. Share Price

NewAmsterdam Pharma Company N.V. Share Price

NASDAQ: NAMS | Mid Cap
$21.58
+$0.28 (1.31%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

NewAmsterdam Pharma Company N.V. Stock Performance

Open
$21.27
Prev. Close
$21.30
Circuit Range
N/A
Day Range
$21.07 - $21.77
Year Range
$20.97 - $42.10
Volume
74,434
Average Traded
$21.49

NewAmsterdam Pharma Company N.V. Share Price Today

As of 10 October 2026, NewAmsterdam Pharma Company N.V.'s share price is $21.58. The stock opened at $21.27, compared to its previous close of $21.30. During today's trading session, NewAmsterdam Pharma Company N.V.'s share price traded between $21.07 and $21.77, with an average price of $21.42. Over the past 52 weeks, the stock has recorded a high of $42.10 and a low of $20.97. In terms of performance, NewAmsterdam Pharma Company N.V.'s share price has declined by 24.41% over the last six months and is down 43.12% on a year-on-year basis.

NewAmsterdam Pharma Company N.V. Share Price Chart

$21.07$21.77
L
Show Current Price
H

NewAmsterdam Pharma Company N.V. Stock Fundamentals & Key Indicators

Market Cap
$2.56B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.17
Revenue (TTM)
$22.50B
Return On Equity (TTM)
-41.10%
Profit Margin
-905.87%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
10.93%

NewAmsterdam Pharma Company N.V. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.35$0.03$3.04$3.70
Net Profit-$72.01-$74.92-$48.44-$64.14
Net Profit Margin-20574.29%-249733.33%-1593.42%-1733.51%
Income ChangeN/A-4.04%35.34%-32.41%

NewAmsterdam Pharma Company N.V. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$102.69$14.09$45.56$22.50
Net Profit-$22.63-$176.94-$241.60-$203.82
Net Profit Margin-22.04%-1255.78%-530.29%-905.87%
Income ChangeN/A-681.88%-36.54%15.64%

About NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

NewAmsterdam Pharma Company N.V. Historical Returns

MonthOpenCloseChange %
Oct 2026
$24.32
$21.59
-11.57%
Sep 2026
$25.42
$24.41
-8.97%
Aug 2026
$27.48
$26.82
-3.40%
Jul 2026
$34.41
$27.77
-18.15%
Jun 2026
$32.71
$33.92
+0.76%
May 2026
$29.11
$33.66
+17.92%
Apr 2026
$32.50
$28.55
-10.78%
Mar 2026
$34.81
$32.00
-9.76%
Feb 2026
$30.77
$35.46
+13.84%
Jan 2026
$35.20
$31.15
-11.20%
Dec 2025
$40.69
$35.08
-15.04%
Nov 2025
$37.73
$41.29
+8.83%

NAMS Share Price FAQs

What is NewAmsterdam Pharma Company N.V. share price today?

chevron-up
NewAmsterdam Pharma Company N.V. share price today is $21.58 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of NewAmsterdam Pharma Company N.V. stock?

chevron-up
The 52 week high of NewAmsterdam Pharma Company N.V. stock is $42.10, while the 52 week low is $20.97 as of 10 Oct '26.

What is NAMS's market capitalisation today?

chevron-up
NAMS market capitalisation is $2.56B as of October 10, 2026, at 4:42 am IST.

What is NAMS's net income for the last quarter?

chevron-up
NAMS's net income for the last quarter is -64.14B USD.

What is the 5 year returns of NAMS?

chevron-up
The 5 year returns of NAMS is 119.98% as on 10 Oct '26.

What is the high & low stock price of NAMS today?

chevron-up
NAMS stock price hit a high of $21.77 and low of $21.07 as of 10 Oct '26.

Can I buy NAMS shares in India?

chevron-up
Yes. You can buy NAMS in India by opening an international trading account.